Source:http://linkedlifedata.com/resource/pubmed/id/15664624
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2005-1-24
|
pubmed:abstractText |
Our recent survey of genes regulated by insulin/IGF-1 signaling (IIS) in Caenorhabditis elegans suggests a role for a number of gene classes in longevity assurance. Based on these findings, we propose a model for the biochemistry of longevity assurance and ageing, which is as follows. Ageing results from molecular damage from highly diverse endobiotic toxins. These are stochastic by-products of diverse metabolic processes, of which reactive oxygen species (ROS) are likely to be only one component. Our microarray analysis suggests a major role in longevity assurance of the phase 1, phase 2 detoxification system involving cytochrome P450 (CYP), short-chain dehydrogenase/reductase (SDR) and UDP-glucuronosyltransferase (UGT) enzymes. Unlike superoxide and hydrogen peroxide detoxification, this system is energetically costly, and requires the excretion from the cell of its products. Given such costs, its activity may be selected against, as predicted by the disposable soma theory. CYP and UGT enzymes target lipophilic molecular species; insufficient activity of this system is consistent with age-pigment (lipofuscin) accumulation during ageing. We suggest that IIS-regulated longevity assurance involves: (a) energetically costly detoxification and excretion of molecular rubbish, and (b) conservation of existing proteins via molecular chaperones. Given the emphasis in this theory on investment in cellular waste disposal, and on protein conservation, we have dubbed it the green theory.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0047-6374
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
126
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
381-7
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:15664624-Animals,
pubmed-meshheading:15664624-Gene Expression Regulation,
pubmed-meshheading:15664624-Humans,
pubmed-meshheading:15664624-Insulin,
pubmed-meshheading:15664624-Insulin-Like Growth Factor I,
pubmed-meshheading:15664624-Longevity,
pubmed-meshheading:15664624-Reactive Oxygen Species,
pubmed-meshheading:15664624-Signal Transduction
|
pubmed:year |
2005
|
pubmed:articleTitle |
Broad spectrum detoxification: the major longevity assurance process regulated by insulin/IGF-1 signaling?
|
pubmed:affiliation |
Department of Biology, University College London, Gower Street, London WC1E 6BT, UK. david.gems@ucl.ac.uk
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|